Odiparcil (SB-424323) is an orally active beta-D-xyloside derivative. Odiparcil can effectively divert the synthesis of cellular glycosaminoglycans (GAG) into secreted soluble species and reduce GAG accumulation. Odiparcil shows antithrombin and antiplatelet activity. Odiparcil can be used for the researches of metabolic and cardiovascular disease, such as mucopolysaccharidoses (MPS) and thrombosis[1][2].
Molekulargewicht:
324.35
Reinheit:
99.98
CAS Nummer:
[137215-12-4]
Formel:
C15H16O6S
Target-Kategorie:
Thrombin
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten